Portal de Periódicos da CAPES

Ten deprescribing articles you should know about: A guide for newcomers to the field

2023; Wiley; Volume: 133; Issue: 6 Linguagem: Inglês

10.1111/bcpt.13877

1742-7843

Wade Thompson, Emily Reeve, Emily G. McDonald, Barbara Farrell, Sion Scott, Michael A. Steinman, Lucas Morin, Carina Lundby,

Medication Adherence and Compliance

Basic & Clinical Pharmacology & ToxicologyEarly View REFLECTION PIECE Ten deprescribing articles you should know about: A guide for newcomers to the field Wade Thompson, Corresponding Author Wade Thompson [email protected] orcid.org/0000-0002-8268-4092 Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark Correspondence Wade Thompson, Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, Canada. Email: [email protected]Search for more papers by this authorEmily Reeve, Emily Reeve orcid.org/0000-0002-1405-999X Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria, Australia Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, South Australia, AustraliaSearch for more papers by this authorEmily G. McDonald, Emily G. McDonald Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Canada Division of Experimental Medicine, Department of Medicine, McGill University Health Centre, Montreal, Canada Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, CanadaSearch for more papers by this authorBarbara Farrell, Barbara Farrell Bruyere Research Institute, Ottawa, Canada Department of Family Medicine, University of Ottawa, Ottawa, Canada University of Waterloo School of Pharmacy, Waterloo, CanadaSearch for more papers by this authorSion Scott, Sion Scott School of Healthcare, University of Leicester, Leicester, UKSearch for more papers by this authorMichael A. Steinman, Michael A. Steinman orcid.org/0000-0002-9564-9480 Division of Geriatrics, Department of Medicine, University of California, San Francisco, California, USA Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, California, USASearch for more papers by this authorLucas Morin, Lucas Morin Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Inserm CIC 1431, CHU Besançon, Besançon, France Inserm U1018, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, FranceSearch for more papers by this authorCarina Lundby, Carina Lundby Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark Hospital Pharmacy Funen, Odense University Hospital, Odense, DenmarkSearch for more papers by this author Wade Thompson, Corresponding Author Wade Thompson [email protected] orcid.org/0000-0002-8268-4092 Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark Correspondence Wade Thompson, Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, 2176 Health Sciences Mall, Vancouver V6T 1Z3, Canada. Email: [email protected]Search for more papers by this authorEmily Reeve, Emily Reeve orcid.org/0000-0002-1405-999X Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria, Australia Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, South Australia, AustraliaSearch for more papers by this authorEmily G. McDonald, Emily G. McDonald Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Canada Division of Experimental Medicine, Department of Medicine, McGill University Health Centre, Montreal, Canada Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, CanadaSearch for more papers by this authorBarbara Farrell, Barbara Farrell Bruyere Research Institute, Ottawa, Canada Department of Family Medicine, University of Ottawa, Ottawa, Canada University of Waterloo School of Pharmacy, Waterloo, CanadaSearch for more papers by this authorSion Scott, Sion Scott School of Healthcare, University of Leicester, Leicester, UKSearch for more papers by this authorMichael A. Steinman, Michael A. Steinman orcid.org/0000-0002-9564-9480 Division of Geriatrics, Department of Medicine, University of California, San Francisco, California, USA Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, California, USASearch for more papers by this authorLucas Morin, Lucas Morin Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Inserm CIC 1431, CHU Besançon, Besançon, France Inserm U1018, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, FranceSearch for more papers by this authorCarina Lundby, Carina Lundby Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark Hospital Pharmacy Funen, Odense University Hospital, Odense, DenmarkSearch for more papers by this author First published: 03 May 2023 https://doi.org/10.1111/bcpt.13877 Funding information: This study did not receive any funding. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL CONFLICT OF INTEREST STATEMENT Authors on this article have authored and collaborated with authors of several of the studies mentioned in this commentary. Dr. Reeve is supported by an NHMRC Investigator Grant (GNT1195460) and grants from the National Institute on Aging (R33-AG057289 and R01-AG070047-01). She also receives royalties for co-authoring a chapter on deprescribing in UpToDate and honorarium from the Society of Hospital Pharmacists of Australia (leading workshops on deprescribing). Sion Scott has/has had research collaborations with INVISIO Pharmaceuticals, Desitin Pharma and iEthico but has no financial interest in the organizations. Michael A. Steinman is supported by grants from the US National Institute on Aging (R24AG064025, K24AG049057, P30AG044281) and receives honoraria from the American Geriatrics Society and from UpToDate for chapter authorship. Dr. McDonald is the creator and owner of the software MedSafer, licenced for used by MedSafer Corp. MedSafer provides electronic decision support for deprescribing. Dr. Farrell has received honoraria from the American College of Clinical Pharmacy for a textbook chapter and from the United States Deprescribing Research Network as a Scientific Advisory Board Member. Dr. Thompson has received a grant from the US Deprescribing Network (US National Institute on Aging). REFERENCES 1Pottegård A, Morin L, Hallas J, et al. Where to begin? Thirty must-read papers for newcomers to pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2022; 31(2): 257- 259. doi:10.1002/pds.5382 2Isenor JE, Bai I, Cormier R, et al. Deprescribing interventions in primary health care mapped to the behaviour change wheel: a scoping review. Res Social Adm Pharm. 2020; 17(7): 1229- 1241. doi:10.1016/j.sapharm.2020.09.005 3Scott IA, Soon J, Elshaug AG, Lindner R. Countering cognitive biases in minimising low value care. Med J Aust. 2017; 206(9): 407- 411. doi:10.5694/mja16.00999 4Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018; 17(12): 1185- 1196. doi:10.1080/14740338.2018.1546841 5Kutner JS, Blatchford PJ, Taylor DH, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial. JAMA Intern Med. 2015; 175(5): 691- 700. doi:10.1001/jamainternmed.2015.0289 6Bayliss EA, Shetterly SM, Drace ML, et al. Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians. JAMA Intern Med. 2022; 182(5): 534- 542. doi:10.1001/jamainternmed.2022.0502 7McDonald EG, Wu PE, Rashidi B, et al. The MedSafer study—electronic decision support for deprescribing in hospitalized older adults. JAMA Intern Med. 2022; 182(3): 265- 273. doi:10.1001/jamainternmed.2021.7429 8Steinman MA, Boyd CM, Spar MJ, Norton JD, Tannenbaum C. Deprescribing and deimplementation: time for transformative change. J am Geriatr Soc. 2021; 69(12): 3693- 3695. doi:10.1111/jgs.17441 9Sawan M, Reeve E, Turner J, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020; 13(3): 233- 245. doi:10.1080/17512433.2020.1730812 10Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006; 166(6): 605- 609. doi:10.1001/archinte.166.6.605 11Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of Care for Older Patients with Multiple Comorbid Diseases. Jama. 2005; 294(6): 716. doi:10.1001/jama.294.6.716 12Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015; 175(5): 827- 834. doi:10.1001/jamainternmed.2015.0324 13Reeve E, Thompson W, Farrell B. Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017; 38: 3- 11. doi:10.1016/j.ejim.2016.12.021 14Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014; 174(6): 890- 898. doi:10.1001/jamainternmed.2014.949 15Sheppard JP, Burt J, Lown M, et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older. Jama. 2020; 323(20): 2039- 2051. doi:10.1001/jama.2020.4871 16Doherty AJ, Boland P, Reed J, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020; 4(3):bjgpopen20X101096. doi:10.3399/bjgpopen20X101096 17Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E. Consumer attitudes towards Deprescribing: a systematic review and meta-analysis. J Gerontol. 2022; 77(5): 1020- 1034. doi:10.1093/gerona/glab222 18Gnjidic D, Johansson M, Meng DM, Farrell B, Langford A, Reeve E. Achieving sustainable healthcare through deprescribing. Cochrane Database Syst Rev. 2022; 2022(10):ED000159. doi:10.1002/14651858.ED000159 19Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS ONE. 2016; 11(8):e0161248. doi:10.1371/journal.pone.0161248 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation